These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39159164)

  • 1. Prognostic utility of exercise cardiovascular magnetic resonance in patients with systemic sclerosis-associated pulmonary arterial hypertension.
    Brown JT; Virsinskaite R; Kotecha T; Steeden JA; Fontana M; Karia N; Schreiber BE; Ong VH; Denton CP; Coghlan JG; Muthurangu V; Knight DS
    Eur Heart J Cardiovasc Imaging; 2024 Aug; ():. PubMed ID: 39159164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced exercise capacity in patients with systemic sclerosis is associated with lower peak tissue oxygen extraction: a cardiovascular magnetic resonance-augmented cardiopulmonary exercise study.
    Brown JT; Kotecha T; Steeden JA; Fontana M; Denton CP; Coghlan JG; Knight DS; Muthurangu V
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):118. PubMed ID: 34706740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.
    Knight DS; Virsinskaite R; Karia N; Cole AR; Maclean RH; Brown JT; Patel RK; Razvi Y; Venneri L; Kotecha T; Martinez-Naharro A; Kellman P; Scott-Russell AM; Schreiber BE; Ong VH; Denton CP; Fontana M; Coghlan JG; Muthurangu V
    Rheumatology (Oxford); 2024 Oct; 63(10):2678-2683. PubMed ID: 38759116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular energetic biomarkers from 4D Flow CMR are associated with exertional capacity in pulmonary arterial hypertension.
    Zhao X; Leng S; Tan RS; Chai P; Yeo TJ; Bryant JA; Teo LLS; Fortier MV; Ruan W; Low TT; Ong CC; Zhang S; van der Geest RJ; Allen JC; Hughes M; Garg P; Tan TH; Yip JW; Tan JL; Zhong L
    J Cardiovasc Magn Reson; 2022 Dec; 24(1):61. PubMed ID: 36451198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Hsu S; Houston BA; Tampakakis E; Bacher AC; Rhodes PS; Mathai SC; Damico RL; Kolb TM; Hummers LK; Shah AA; McMahan Z; Corona-Villalobos CP; Zimmerman SL; Wigley FM; Hassoun PM; Kass DA; Tedford RJ
    Circulation; 2016 Jun; 133(24):2413-22. PubMed ID: 27169739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
    Cho IJ; Oh J; Chang HJ; Park J; Kang KW; Kim YJ; Choi BW; Shin S; Shim CY; Hong GR; Ha JW; Chung N
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):18-23. PubMed ID: 23704751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study.
    Baillie TJ; Sidharta S; Steele PM; Worthley SG; Willoughby S; Teo K; Sanders P; Nicholls SJ; Worthley MI
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):3. PubMed ID: 28065166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of biventricular strain and assessment of ventriculo-ventricular interaction in pulmonary arterial hypertension using exercise cardiac magnetic resonance imaging and myocardial feature tracking.
    Lin ACW; Seale H; Hamilton-Craig C; Morris NR; Strugnell W
    J Magn Reson Imaging; 2019 May; 49(5):1427-1436. PubMed ID: 30353959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.
    Simpson CE; Kolb TM; Hsu S; Zimmerman SL; Corona-Villalobos CP; Mathai SC; Damico RL; Hassoun PM
    Pulm Circ; 2022 Jan; 12(1):e12005. PubMed ID: 35506079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.
    Hsu S; Kokkonen-Simon KM; Kirk JA; Kolb TM; Damico RL; Mathai SC; Mukherjee M; Shah AA; Wigley FM; Margulies KB; Hassoun PM; Halushka MK; Tedford RJ; Kass DA
    Circulation; 2018 May; 137(22):2360-2370. PubMed ID: 29352073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment - predictors of procedure success and duration in pulmonary artery hypertension.
    Knight DS; Kotecha T; Martinez-Naharro A; Brown JT; Bertelli M; Fontana M; Muthurangu V; Coghlan JG
    J Cardiovasc Magn Reson; 2019 Sep; 21(1):57. PubMed ID: 31495338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
    Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance.
    Noguchi A; Kato M; Kono M; Ohmura K; Ohira H; Tsujino I; Oyama-Manabe N; Oku K; Bohgaki T; Horita T; Yasuda S; Nishimura M; Atsumi T
    Mod Rheumatol; 2017 May; 27(3):481-488. PubMed ID: 27535805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.
    Alabed S; Garg P; Alandejani F; Dwivedi K; Maiter A; Karunasaagarar K; Rajaram S; Hill C; Thomas S; Gossling R; Sharkey MJ; Salehi M; Wild JM; Watson L; Hameed A; Charalampopoulos A; Lu H; Rothman AMK; Thompson AAR; Elliot CA; Hamilton N; Johns CS; Armstrong I; Condliffe R; van der Geest RJ; Swift AJ; Kiely DG
    Eur Respir J; 2023 Aug; 62(2):. PubMed ID: 37414419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial adaptation and exercise performance in patients with pulmonary arterial hypertension assessed with patient-specific computer simulations.
    Olsen NT; Göransson C; Vejlstrup N; Carlsen J
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H865-H880. PubMed ID: 34448636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
    Celant LR; Wessels JN; Marcus JT; Meijboom LJ; Bogaard HJ; de Man FS; Vonk Noordegraaf A
    Chest; 2024 Jan; 165(1):181-191. PubMed ID: 37527773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension.
    Wensel R; Francis DP; Meyer FJ; Opitz CF; Bruch L; Halank M; Winkler J; Seyfarth HJ; Gläser S; Blumberg F; Obst A; Dandel M; Hetzer R; Ewert R
    Int J Cardiol; 2013 Aug; 167(4):1193-8. PubMed ID: 22494868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Magnetic Resonance Derived Left Ventricular Eccentricity Index and Right Ventricular Mass Measurements Predict Outcome in Children with Pulmonary Arterial Hypertension.
    Haarman MG; Coenraad I; Hagdorn QAJ; Hillege HL; Willems TP; Berger RMF; Douwes JM
    Children (Basel); 2023 Apr; 10(4):. PubMed ID: 37190005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.
    Knight DS; Karia N; Cole AR; Maclean RH; Brown JT; Masi A; Patel RK; Razvi Y; Chacko L; Venneri L; Kotecha T; Martinez-Naharro A; Kellman P; Scott-Russell AM; Schreiber BE; Ong VH; Denton CP; Fontana M; Coghlan JG; Muthurangu V
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):463-471. PubMed ID: 35775814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.